EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program

Snigdha Gulati, Mohak Gupta, TingTing Yan, Sneha Yelamanchili, Lucy Qinghua Xu, Tina Bharani, Ali Naji, Divyansh Agarwal iD

PharmacoEconomics · 2024-11 · 42 (11) · 1279-1286

DOI: 10.1007/s40273-024-01426-3 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PharmacoEconomics, online erschienen am 21.08.2024. Verfasst von Snigdha Gulati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Thoracic Surgery, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Drugs, Generic, Medicare Part D, Drug Costs, Cost Savings. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, GenericMedicare Part DDrug CostsCost SavingsUnited StatesHumansRetrospective StudiesCubaDrug IndustryPrescription Drugs

Substanzen

Drugs, GenericPrescription Drugs

Autor:innen und Institutionen

  • Department of General and Thoracic Surgery, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Faculty of Arts and Sciences, Harvard University, Cambridge, MA, USA.
  • Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
  • Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Department of Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, GRB 425, Boston, MA, 02114, USA. dagarwal@mgh.harvard.edu.

ORCID-Profile: Divyansh Agarwal

Zitieren

APA

Gulati, S., Gupta, M., Yan, T., Yelamanchili, S., Xu, L. Q., Bharani, T., Naji, A., & Agarwal, D. (2024). Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program. PharmacoEconomics, 42(11), 1279-1286. https://doi.org/10.1007/s40273-024-01426-3

Vancouver

Gulati S, Gupta M, Yan T, Yelamanchili S, Xu LQ, Bharani T, et al. Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program. PharmacoEconomics. 2024;42(11):1279-1286. doi:10.1007/s40273-024-01426-3

BibTeX
@article{Gulati2024,
  author = {Gulati, Snigdha and Gupta, Mohak and Yan, TingTing and Yelamanchili, Sneha and Xu, Lucy Qinghua and Bharani, Tina and Naji, Ali and Agarwal, Divyansh},
  title = {Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program},
  journal = {PharmacoEconomics},
  year = {2024},
  volume = {42},
  number = {11},
  pages = {1279--1286},
  doi = {10.1007/s40273-024-01426-3}
}
Kostenlos starten →